The company said that its net income attributable to UHS for Q4 2024 was $332.4 million ($4.96 per diluted share), up from $216.4 million ($3.16 per share) a year earlier, and that net revenues rose 11.1% to $4.114 billion.

1. 01

   The company said that its net income attributable to UHS for Q4 2024 was $332.4 million ($4.96 per diluted share), up from $216.4 million ($3.16 per share) a year earlier, and that net revenues rose 11.1% to $4.114 billion.

2. 02

   Universal Health Services said its net income attributable to UHS for fiscal 2024 was $1.142 billion ($16.82 per diluted share), and that net revenues rose 10.8% to $15.828 billion. It also said Adjusted EBITDA net of NCI was $2.246 billion for 2023, compared with $1.742 billion for the prior year.

3. 03

   The company said net cash provided by operating activities for 2024 was $2.067 billion, up $799 million from $1.268 billion in 2023. As of December 31, 2024, it said it had $1.17 billion of aggregate available borrowing capacity under its $1.3 billion revolving credit facility, net of outstanding borrowings and letters of credit.

4. 04

   Universal Health Services said it expects net revenues for 2025 of $17.020 billion to $17.364 billion, Adjusted EBITDA net of NCI of $2.357 billion to $2.484 billion, and EPS-diluted of $18.45 to $19.95.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.